GLP-1 Agonist Semaglutide Brand names: Ozempic (diabetes) Wegovy (weight loss) 1517% Average body weight reduction (STEP trials) Activates GLP-1 receptors in gut and brain Suppresses appetite, slows gastric emptying Regulates blood sugar and insulin response Weekly subcutaneous injection or daily oral (Rybelsus) Cardiovascular outcome data: SELECT trial (2023) Dual GLP-1 + GIP Agonist Tirzepatide Brand names: Mounjaro (diabetes) Zepbound (weight loss) 2022% Average body weight reduction (SURMOUNT trials) Activates both GLP-1 AND GIP receptors Stronger effect on insulin sensitivity than semaglutide alone Greater fat loss, especially visceral fat Weekly subcutaneous injection only Head-to-head vs semaglutide: SURPASS-6 favors tirzepatide The core difference is the receptor target
Additionally, newer formulations and higher doses are being explored, which could further enhance its effectiveness for weight loss
MRP ( inclusive of all taxes ) : 2600/- A Dermatologically formulated 2 in 1 advanced, double action formula to achieve radiant and glowing skin
Related Reading Can I Increase Nad Based On My Genetics Lifemd Tirzepatide Goodlife Meds Tirzepatide Noom Tirzepatide Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
&What Is Heavy Metal Toxicity
3 Johns Hopkins Medicine
